Basketball, the enemy and antitrust lawsuits: this week's quiz
Here are five questions on the past week’s IP developments. Answers next week
1. Which individual topped Managing IP’s list of the most influential people in IP?
2. The Court of Justice ruled in a case relating to supplementary protection certificates last week. What condition does Neurim Pharmaceuticals’ product Circadin treat?
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.